Unverified50% confidenceFactExact time
The FDA has designated psilocybin as a Breakthrough Therapy, allowing for an expedited review process
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/10/2026
First Seen
Valid until: 1/8/2027
Sources
Related Entities
Related Claims
UnverifiedFollowing the Holmes case, the FDA strengthened its regulatory scrutiny of medical technology startups.72% similarUnverifiedDrug repurposing refers to applying drugs that have already been approved for market or have completed part of clinical trials to treat diseases beyond their original indications, which can significantly compress the preclinical research timeline and reduce R&D costs.69% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/995214API
curl https://kongchang.com/api/v1/knowledge/claims/995214MCP
get_claim(id=995214)